Although the precise role of COX-2 in cardiac physiology and diseases remains not fully understood and controversial, there are progressively increased reports showing that pharmacological inhibitors of COX-2 could reduce recurrent angina, myocardial infarction, and death [2]. This evidence concerns the gene PTGS2 and myocardial infarction.